BiDe Pharmaceutical (688073.SH) shareholders Zhoushan Xinxing, Ningbo Landan and their concerted actors plan to reduce their shareholding by no more than 2.86%.

Zhijun Finance and Economics APP News: Bi De Medicine (688073.SH) announced that the company's shareholders Zhoushan Xingxi, Ningbo Landan, and their concerted action person Mr. Wu Bo plan to reduce their holdings of the company's shares. Among them, Zhoushan Xingxi plans to reduce the number of company shares held through block trading by no more than 908,800 shares, or not more than 1.00% of the total share capital of the company; Ningbo Landan plans to reduce the number of company shares held through block trading by no more than 908,800 shares, or not more than 1.00% of the total share capital of the company; shareholder Wu Bo plans to reduce the number of company shares held through centralized competitive trading by no more than 785,800 shares, or not more than 0.86% of the total share capital of the company.